BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a naturally occurring protective protein found in human gastric juice. This stable peptide fragment was isolated from the body's own gastrointestinal protective secretions, where it plays a role in maintaining and repairing the stomach lining under normal physiological conditions.
BPC-157 exerts its regenerative effects through multiple coordinated mechanisms: it promotes angiogenesis (new blood vessel formation) at injury sites, modulates the nitric oxide system to regulate blood flow and inflammation, upregulates growth hormone receptors, and activates the FAK-paxillin signaling pathway critical for cell migration and tissue repair. These overlapping pathways accelerate the healing cascade for tendons, ligaments, muscles, nerves, and the gastrointestinal lining.
Since its initial characterization in the early 1990s, BPC-157 has been studied in over 100 preclinical trials demonstrating efficacy across a wide range of tissue types. While human clinical trials remain limited, the consistent and reproducible results across animal models — including tendon-to-bone healing, muscle crush injuries, nerve transection, and inflammatory bowel models — have made BPC-157 one of the most widely prescribed regenerative peptides in clinical practice.
The injectable formulation at 3mg/mL delivers BPC-157 subcutaneously for direct systemic distribution. Subcutaneous administration provides high bioavailability and allows the peptide to reach injured tissues through the bloodstream, making it particularly effective for systemic recovery protocols rather than localized application alone.
Clinician-supervised, delivered to your door.
